<DOC>
	<DOCNO>NCT01962077</DOCNO>
	<brief_summary>assess effect MedCem MTA pulp medicament follow pulpotomy human primary molar carious pulp exposure comparison Formocresol .</brief_summary>
	<brief_title>Comparison MedCem MTA Formocresol Used Pulpotomies Primary Teeth .</brief_title>
	<detailed_description />
	<criteria>1. healthy child 2. Asymptomatic primary molar deep carious lesion ; 3 . Exposure vital pulp caries ; 4 . No clinical radiographic evidence pulp degeneration , excessive bleeding root canal , internal root resorption , interradicular and/or periapical bone destruction , swell , sinus tract ; 5 . Ability perform leakage free restoration teeth use stainless steel crown , amalgam/resin base restoration .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>pulpotomy</keyword>
	<keyword>MTA</keyword>
	<keyword>primary teeth</keyword>
	<keyword>formocresol</keyword>
</DOC>